Symptoms
Common signs and symptoms of Carcinoid Syndrome include:
When to see a doctor
If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.
Causes & Risk Factors
Several factors can contribute to Carcinoid Syndrome.
Carcinoid syndrome develops when neuroendocrine tumors produce excessive amounts of hormones, particularly serotonin, that flood the bloodstream.
Carcinoid syndrome develops when neuroendocrine tumors produce excessive amounts of hormones, particularly serotonin, that flood the bloodstream. These tumors most commonly arise in the small intestine, appendix, rectum, or lungs, where specialized cells normally produce small amounts of hormones to help regulate various body functions. When these cells become cancerous, they lose their normal regulatory controls and begin churning out hormones at dangerously high levels.
The syndrome typically manifests only after tumors have spread beyond their original location, especially to the liver.
The syndrome typically manifests only after tumors have spread beyond their original location, especially to the liver. This happens because the liver normally breaks down excess hormones before they can cause problems throughout the body. When carcinoid tumors establish themselves in the liver, or when lung tumors release hormones directly into the circulation bypassing the liver, these powerful chemical messengers reach tissues throughout the body and trigger the characteristic symptoms.
Several factors can trigger acute episodes in people who already have the condition.
Several factors can trigger acute episodes in people who already have the condition. Common triggers include alcohol consumption, certain foods like aged cheeses or cured meats, physical or emotional stress, certain medications, and medical procedures. The tumors themselves may also release hormone bursts spontaneously, making some episodes unpredictable even when people carefully avoid known triggers.
Risk Factors
- Family history of neuroendocrine tumors
- Multiple endocrine neoplasia type 1 syndrome
- Neurofibromatosis type 1
- Age over 50 years
- Previous diagnosis of carcinoid tumors
- Chronic atrophic gastritis
- Pernicious anemia
- Zollinger-Ellison syndrome
- History of other gastrointestinal cancers
Diagnosis
How healthcare professionals diagnose Carcinoid Syndrome:
- 1
Diagnosing carcinoid syndrome often begins when doctors notice the characteristic pattern of flushing, diarrhea, and breathing problems, especially if these symptoms occur together in episodes.
Diagnosing carcinoid syndrome often begins when doctors notice the characteristic pattern of flushing, diarrhea, and breathing problems, especially if these symptoms occur together in episodes. The diagnostic process typically starts with measuring levels of 5-HIAA (5-hydroxyindoleacetic acid) in a 24-hour urine collection, which represents the breakdown product of excess serotonin. Patients must avoid certain foods like bananas, avocados, and walnuts for several days before this test, as these can artificially elevate results. Blood tests measuring chromogranin A and sometimes serotonin levels provide additional hormone evidence.
- 2
Imaging studies play a crucial role in locating the underlying tumors and determining how far they have spread.
Imaging studies play a crucial role in locating the underlying tumors and determining how far they have spread. CT scans and MRI help identify liver metastases and other tumor locations, while specialized scans called octreotide scans use radioactive tracers that bind specifically to neuroendocrine tumors. These nuclear medicine studies can detect tumors that don't show up clearly on conventional imaging. PET scans with specific tracers like gallium-68 DOTATATE provide even more detailed pictures of tumor distribution throughout the body.
- 3
Doctors must rule out other conditions that can cause similar symptoms, including menopause, hyperthyroidism, inflammatory bowel disease, mastocytosis, and panic disorder.
Doctors must rule out other conditions that can cause similar symptoms, including menopause, hyperthyroidism, inflammatory bowel disease, mastocytosis, and panic disorder. The combination of biochemical evidence, imaging findings, and clinical symptoms usually provides a clear diagnosis. In some cases, tissue biopsy may be needed to confirm the presence of neuroendocrine tumors and determine their specific characteristics, which helps guide treatment decisions.
Complications
- The most serious complication of carcinoid syndrome involves damage to heart valves, particularly on the right side of the heart, which occurs in about 50% of patients with long-standing disease.
- Excess serotonin causes scarring and thickening of the tricuspid and pulmonary valves, potentially leading to heart failure if left untreated.
- Regular heart monitoring with echocardiograms helps detect these changes early, and valve replacement surgery may become necessary in severe cases.
- Carcinoid crisis represents a life-threatening emergency where massive hormone release causes dangerous drops in blood pressure, severe breathing problems, and potentially fatal heart rhythm abnormalities.
- This crisis can be triggered by anesthesia, medical procedures, or severe stress, making it crucial for all healthcare providers to know about a patient's carcinoid syndrome before any medical intervention.
- Other complications include severe malnutrition from chronic diarrhea, kidney problems from long-term medication use, and progressive tumor growth affecting organ function.
Prevention
- Primary prevention of carcinoid syndrome isn't possible since the underlying tumors typically develop without clear preventable causes.
- However, people with known risk factors like family history of neuroendocrine tumors or genetic syndromes can benefit from regular medical monitoring and screening discussions with their healthcare providers.
- Early detection of carcinoid tumors before they spread and develop into full syndrome offers the best outcomes.
- For those already diagnosed with carcinoid tumors, preventing progression to carcinoid syndrome involves regular monitoring with blood and urine tests to catch early signs of hormone overproduction.
- Prompt treatment of localized tumors through surgery or other interventions can prevent the spread that typically leads to syndrome development.
- People with carcinoid tumors should maintain regular follow-up care and report any new symptoms promptly to their medical team.
Treatment for carcinoid syndrome focuses on controlling hormone production while addressing the underlying tumors through a multi-pronged approach.
Treatment for carcinoid syndrome focuses on controlling hormone production while addressing the underlying tumors through a multi-pronged approach. Somatostatin analogs like octreotide and lanreotide form the cornerstone of medical therapy, administered as monthly injections that significantly reduce hormone release and control symptoms in most patients. These medications can decrease flushing episodes by 70-80% and improve diarrhea in similar percentages. For breakthrough symptoms, short-acting octreotide injections provide rapid relief during acute episodes.
When somatostatin analogs alone prove insufficient, doctors may add medications targeting specific symptoms.
When somatostatin analogs alone prove insufficient, doctors may add medications targeting specific symptoms. Anti-diarrheal agents like loperamide help control bowel movements, while antihistamines can reduce flushing severity. For patients with heart valve problems related to the syndrome, medications to support heart function become necessary. Newer treatments include telotristat ethyl, which blocks serotonin production in the intestines and can significantly improve diarrhea that doesn't respond to other treatments.
Tumor-directed therapies aim to reduce the source of hormone production through various approaches.
Tumor-directed therapies aim to reduce the source of hormone production through various approaches. Surgical removal remains the preferred option when tumors are localized and operable, potentially offering cure or long-term control. For widespread disease, treatments include hepatic artery embolization to cut off blood supply to liver tumors, radiofrequency ablation to destroy tumor tissue, and peptide receptor radionuclide therapy (PRRT) using radioactive substances that target tumor cells specifically. Chemotherapy may be considered for more aggressive tumors, though carcinoid tumors generally respond less predictably to traditional cancer drugs.
Emerging treatments show promising results in clinical trials, including new radioactive therapies, targeted drugs that block specific growth pathways, and immunotherapy approaches.
Emerging treatments show promising results in clinical trials, including new radioactive therapies, targeted drugs that block specific growth pathways, and immunotherapy approaches. Combination strategies that attack tumors through multiple mechanisms simultaneously are becoming more sophisticated, offering hope for better long-term control. The key lies in individualizing treatment based on tumor characteristics, symptom severity, and patient overall health status.
Living With Carcinoid Syndrome
Managing daily life with carcinoid syndrome requires learning to identify and avoid personal triggers while maintaining effective medication schedules. Many people find keeping a symptom diary helps identify patterns and triggers, whether related to specific foods, stress levels, or activities. Working closely with a specialized medical team that understands neuroendocrine tumors makes a significant difference in treatment outcomes and quality of life.
Latest Medical Developments
Latest medical developments are being researched.
Frequently Asked Questions
Update History
Apr 27, 2026v1.0.0
- Published by DiseaseDirectory